tiprankstipranks
Trending News
More News >
Universal Health (UHS)
NYSE:UHS
US Market

Universal Health (UHS) Ratios

Compare
492 Followers

Universal Health Ratios

UHS's free cash flow for Q1 2025 was $0.11. For the 2025 fiscal year, UHS's free cash flow was decreased by $ and operating cash flow was $0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.27 1.40 1.33 1.14 1.32
Quick Ratio
1.17 1.29 1.21 1.04 1.25
Cash Ratio
0.06 0.06 0.05 0.06 0.49
Solvency Ratio
0.22 0.17 0.17 0.22 0.21
Operating Cash Flow Ratio
0.94 0.63 0.52 0.45 0.95
Short-Term Operating Cash Flow Coverage
18.02 6.39 6.67 7.83 6.02
Net Current Asset Value
$ -4.89B$ -4.95B$ -4.99B$ -4.63B$ -3.79B
Leverage Ratios
Debt-to-Assets Ratio
0.34 0.38 0.39 0.35 0.31
Debt-to-Equity Ratio
0.73 0.87 0.89 0.75 0.66
Debt-to-Capital Ratio
0.42 0.47 0.47 0.43 0.40
Long-Term Debt-to-Capital Ratio
0.39 0.43 0.44 0.40 0.35
Financial Leverage Ratio
2.14 2.27 2.28 2.15 2.13
Debt Service Coverage Ratio
6.39 3.80 5.19 8.25 3.15
Interest Coverage Ratio
8.97 5.81 7.91 16.29 12.78
Debt to Market Cap
0.38 0.47 0.47 0.39 0.33
Interest Debt Per Share
77.28 80.33 73.83 56.27 50.56
Net Debt to EBITDA
2.13 3.01 3.15 2.31 1.59
Profitability Margins
Gross Profit Margin
89.97%89.27%89.00%88.71%88.86%
EBIT Margin
10.62%8.04%7.38%10.89%11.75%
EBITDA Margin
14.31%12.21%12.26%15.25%16.18%
Operating Profit Margin
10.63%8.23%7.49%10.78%11.75%
Pretax Profit Margin
9.46%6.58%6.46%10.23%10.83%
Net Profit Margin
7.22%5.03%5.04%7.84%8.17%
Continuous Operations Profit Margin
7.35%5.04%4.90%7.81%8.24%
Net Income Per EBT
76.24%76.33%77.99%76.67%75.39%
EBT Per EBIT
89.07%80.01%86.32%94.88%92.18%
Return on Assets (ROA)
7.89%5.14%5.01%7.57%7.00%
Return on Equity (ROE)
16.92%11.67%11.41%16.28%14.94%
Return on Capital Employed (ROCE)
13.72%9.83%8.67%12.27%12.35%
Return on Invested Capital (ROIC)
10.49%7.35%6.45%9.22%9.03%
Return on Tangible Assets
10.84%7.15%7.05%10.86%9.84%
Earnings Yield
9.56%6.79%6.56%9.27%8.07%
Efficiency Ratios
Receivables Turnover
7.27 6.38 6.64 7.24 6.69
Payables Turnover
2.51 2.50 2.32 2.17 2.26
Inventory Turnover
7.19 7.06 6.75 6.90 6.76
Fixed Asset Turnover
2.26 2.18 2.10 2.03 2.02
Asset Turnover
1.09 1.02 0.99 0.97 0.86
Working Capital Turnover Ratio
22.55 20.10 29.70 23.41 20.04
Cash Conversion Cycle
-44.27 -37.33 -48.54 -65.19 -53.11
Days of Sales Outstanding
50.22 57.20 54.96 50.43 54.60
Days of Inventory Outstanding
50.79 51.67 54.10 52.90 53.96
Days of Payables Outstanding
145.28 146.20 157.60 168.52 161.66
Operating Cycle
101.01 108.87 109.06 103.33 108.55
Cash Flow Ratios
Operating Cash Flow Per Share
31.06 18.29 13.62 10.71 27.75
Free Cash Flow Per Share
16.88 7.57 3.58 0.34 19.12
CapEx Per Share
14.18 10.72 10.04 10.37 8.63
Free Cash Flow to Operating Cash Flow
0.54 0.41 0.26 0.03 0.69
Dividend Paid and CapEx Coverage Ratio
2.07 1.59 1.26 0.96 3.14
Capital Expenditure Coverage Ratio
2.19 1.71 1.36 1.03 3.21
Operating Cash Flow Coverage Ratio
0.42 0.24 0.19 0.19 0.56
Operating Cash Flow to Sales Ratio
0.13 0.09 0.07 0.07 0.20
Free Cash Flow Yield
9.41%4.97%2.54%0.26%13.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
10.46 14.72 15.25 10.79 12.39
Price-to-Sales (P/S) Ratio
0.75 0.74 0.77 0.85 1.01
Price-to-Book (P/B) Ratio
1.77 1.72 1.74 1.76 1.85
Price-to-Free Cash Flow (P/FCF) Ratio
10.63 20.14 39.32 381.63 7.19
Price-to-Operating Cash Flow Ratio
5.78 8.34 10.34 12.11 4.96
Price-to-Earnings Growth (PEG) Ratio
0.16 1.21 -0.66 1.35 0.59
Price-to-Fair Value
1.77 1.72 1.74 1.76 1.85
Enterprise Value Multiple
7.40 9.07 9.42 7.86 7.84
Enterprise Value
16.77B 15.81B 15.47B 15.14B 14.67B
EV to EBITDA
7.40 9.07 9.42 7.86 7.84
EV to Sales
1.06 1.11 1.15 1.20 1.27
EV to Free Cash Flow
14.93 30.14 59.04 540.15 9.02
EV to Operating Cash Flow
8.11 12.47 15.53 17.14 6.21
Tangible Book Value Per Share
42.52 31.63 27.11 26.11 28.70
Shareholders’ Equity Per Share
101.41 88.70 80.97 73.80 74.27
Tax and Other Ratios
Effective Tax Rate
0.22 0.24 0.24 0.24 0.24
Revenue Per Share
237.82 206.03 183.26 153.20 135.89
Net Income Per Share
17.16 10.35 9.24 12.02 11.10
Tax Burden
0.76 0.76 0.78 0.77 0.75
Interest Burden
0.89 0.82 0.88 0.94 0.92
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.48 0.51 0.51 0.50 0.50
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.78 1.77 1.52 0.89 2.48
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis